Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A3374 DronedaroneTarget: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4 and 2D6 inhibitor,moderate
-
A4313 Cobicistat (GS-9350)Target: Cytochrome P450 (CYP450)Summary: Selective CYP3A inhibitor
-
A4320 VoriconazoleSummary: CYP51 inhibitor
-
A4322 ClarithromycinTarget: Cytochrome P450 (CYP450)Summary: CYP3A inhibitor, potent
-
B5963 7-EthoxyresorufinTarget: Cytochrome P450 (CYP450)Summary: Specific subtrate of CYP1A
-
B5990 DiosmetinSummary: CYP1A1 inhibitor
-
C4880 6,7-dihydroxy BergamottinSummary: potent inhibitor of CYP3A4
-
C4691 4-phenyl-1,2,3-ThiadiazoleSummary: selective inhibitor of certain CYP450 enzymes (CYP2B4, CYP2E1)
-
C5228 DDMSSummary: CYP4A2 enzyme inhibitor
-
C5234 PPOHSummary: inhibitor of CYP epoxidase activity on arachadonic acid